Cytotron was invented in India by the Indian Researcher, Dr. Rajah Vijay Kumar, at the Centre for Advanced Research and Development (CARD), after 27 years of research in understanding cellular pathways and interactions with specifically modulated fast radio bursts. “It is been a great feeling that after so many years of hard work against all odds, a prestigious institution like the USFDA is designating our work as a “breakthrough” in the treatment of Liver, Pancreas and Breast Cancers, three notorious ones”, said Dr. R. V. Kumar.
“The Cytotron is intended to be used to cause degeneration of uncontrolled growth of tissues. It is indicated for treating protein-linked, abnormally regenerating disorders such as Neoplastic disease, and allowing extended progression free survival, with pain relief, palliation, improved quality and dignity of life. It is indicated for the treatment of solid tumors of breast, Liver and Pancreas – We are pleased to Inform you that your device and proposed Indication for use meet the criteria and have been granted designation as a Breakthrough Device” said the communication from The Centre for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (US.FDA).